MedCitizens

StartUPDATES: New Developments from Healthcare Startups

Check out news from Alpha Sophia, Triomics, In-House Health, and Humanaut Health.

Alpha Sophia, a premier platform for commercial intelligence in healthcare, has launched its new podcast series, Alpha Sophia Spotlight. Aimed at medtech startups and small to medium-sized businesses (SMBs), the series features interviews with industry innovators and leaders, hosted by Alpha Sophia’s own executives. The podcast delves into go-to-market strategies, development, and commercialization of medtech and digital health products, along with visionary leadership insights.

The first episodes include discussions with leaders from OssiformUbie, and Custom Medical Marketing, offering valuable perspectives from the forefront of medical technology. Available on SpotifyApple Podcasts, and YouTube under “‘Alpha Sophia Spotlight,” this series is great listening for anyone interested in the future of healthcare technology.


Triomics has raised a $15 million Series A round from Lightspeed, Nexus Venture Partners, General Catalyst and Y Combinator. The company uses AI to extract data from electronic health records (EHRs) for several different uses such as identifying suitable clinical trials for each patient, helping doctors to prepare for patient visits and assisting in submission of cancer data to state regulatory agencies, according to TechCrunch

To learn more, click here.


sponsored content

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.

In-House Health seeks to restore sustainability to nursing. It has officially launched its AI-driven scheduling and management platform for modern nursing teams. The health tech company, founded in 2023, recently raised $4 million in seed funding led by NEA and TMV, with pre-seed investment from Vine Ventures and Longevity Venture Partners.

In-House’s AI algorithm is trained on millions of patient records to identify patterns of bedside care and anticipate shift changes. The algorithm can shorten hours spent on scheduling by half or more and reduce labor costs by over 10% across-the-board, amid the growing crisis of workforce shortage and spiraling costs to deliver care.

To learn more, click here.

Humanaut Health, a clinic for health optimization and longevity, raised $8.7 million in seed investment. The Kabech Fund led the seed round with participation from Midnight Venture Partners, the company’s founders, Tushara Dilanie, and other strategic individual investors. The financing will support care model development – which includes regenerative, hormone, and lifestyle medicine services – and its expansion of membership-based clinics to major U.S. markets.

Its clinic services include comprehensive health assessments, preventative care, symptom management, and individual coaching delivered via premium membership. Investments are earmarked for clinic quality, digital health services, and franchise expansion strategies.

To learn more, click here.

Photo: champpixs, Getty Images